drugset / Trial / NCT05108077

Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells

NCT05108077

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Treatment of metastatic tumors of the urogenital area with cytokine-induced killer cells

Timeline

Start
2022-03-01
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject CIK cells Cell therapy Intravenous